Breast: EmpowHER-208
Trial ID
07102381
Trial Sponsor
Jazz Pharmaceuticals
A Phase 2, Randomized, Multicenter, Open-Label Neoadjuvant Study of Zanidatamab in Combination with Chemotherapy in Participants with HER2-Positive Breast Cancer
- NCT: 07102381